Since FG cells express relatively low levels of NRP-1 at baseline, we utilised the Panc-1 cell line, a human pancreatic cancer cell line with endogenously high levels of NRP-1 to develop clones with downregulated NRP-1 expression, utilising siRNA technology. This evidence concerns the gene NRP1 and pancreatic neoplasm.